title: Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
authors.forename: Ashley
authors.initials: A
authors.lastname: Minuk
authors.forename: Michel J
authors.initials: MJ
authors.lastname: Belliveau
authors.forename: David R P
authors.initials: DR
authors.lastname: Almeida
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Dorrepaal
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Gale
mesh_terms: D000284:Administration, Oral; D005260:Female; D000068876:Fingolimod Hydrochloride; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056965:Injections, Intraocular; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D011409:Propylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D013110:Sphingosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage*
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D014221:Triamcinolone; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine